VPAC receptor mediated tumor cell targeting by protamine based nanoparticles. 2010

Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
Institute of Cancer Research, Medical University of Vienna, KIM-1, Vienna, Austria.

The receptors for vasoactive intestinal peptide (VIP), VPAC1-, VPAC2-, and PAC1-receptor are overexpressed by various tumor cells. VIP can target these receptors and transport conjugates into the cell. However, the use of VIP for tumor cell targeting is hampered by the peptides short half-lives due to enzymatic degradation. Because protamine-based nanoparticles (proticles) protect the peptide and serve as peptide depot, we explored the potential of proticles as carrier for VIP-conjugated molecules. The VIP-loaded proticles were stable as shown by Fluorescence Correlation Spectroscopy. With Confocal Laser Scanning Microscopy, we observed VIP-loaded proticles to specifically target the tumor cells. The cell binding triggered the substance release and conjugate internalization of VIP-Cy3 in vitro and ex vivo by human tumors. We observed VIP releasing proticle depots distributed in rat tissue and human tumors. Our findings warrant further studies to explore the proticles potential to enable peptide-mediated targeting for in vivo and clinical applications.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001158 Arteries The vessels carrying blood away from the heart. Artery
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence
D014660 Vasoactive Intestinal Peptide A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE). VIP (Vasoactive Intestinal Peptide),Vasoactive Intestinal Polypeptide,Vasointestinal Peptide,Intestinal Peptide, Vasoactive,Intestinal Polypeptide, Vasoactive,Peptide, Vasoactive Intestinal,Peptide, Vasointestinal,Polypeptide, Vasoactive Intestinal

Related Publications

Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
January 2010, Expert opinion on drug delivery,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
December 2015, Nanoscale research letters,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
May 2024, International journal of molecular sciences,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
January 2006, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
June 2017, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
January 2016, Theranostics,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
April 2011, Molecular cancer therapeutics,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
December 2016, Colloids and surfaces. B, Biointerfaces,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
January 2017, Pharmaceutical research,
Anna Ortner, and Karin Wernig, and Raphaela Kaisler, and Michael Edetsberger, and Franz Hajos, and Gottfried Köhler, and Wilhelm Mosgoeller, and Andreas Zimmer
January 2019, Frontiers in chemistry,
Copied contents to your clipboard!